Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial
BMC Cardiovascular Disorders 2012, 12:65 doi:10.1186/1471-2261-12-65
Pre-publication versions of this article and reviewers' reports
|Original Submission - Version 1||15 May 2012|
|Editor's comment||01 Aug 2012|
|Editorial acceptance||01 Aug 2012|
|Published||16 Aug 2012|
Due to technical difficulties, the pre-publication history may be incomplete. If you require any further information please contact the journal.